| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.31B | 60.30B | 66.28B | 60.38B | 55.89B | 48.39B |
| Gross Profit | 15.46B | 13.21B | 15.74B | 12.83B | 11.58B | 9.93B |
| EBITDA | 11.71B | 8.66B | 12.62B | 9.17B | 7.47B | 6.40B |
| Net Income | 7.99B | 5.49B | 8.46B | 6.24B | 4.68B | 3.79B |
Balance Sheet | ||||||
| Total Assets | 84.53B | 85.60B | 88.58B | 84.43B | 77.51B | 71.15B |
| Cash, Cash Equivalents and Short-Term Investments | 33.79B | 36.81B | 33.66B | 31.69B | 29.32B | 27.49B |
| Total Debt | 800.00M | 800.00M | 975.00M | 895.00M | 845.00M | 1.03B |
| Total Liabilities | 16.61B | 16.07B | 19.37B | 20.56B | 18.06B | 15.22B |
| Stockholders Equity | 67.32B | 69.00B | 68.57B | 63.39B | 59.05B | 55.56B |
Cash Flow | ||||||
| Free Cash Flow | -159.50M | 6.19B | 4.94B | 5.22B | 3.13B | 6.92B |
| Operating Cash Flow | 775.50M | 6.65B | 6.94B | 7.13B | 4.07B | 7.17B |
| Investing Cash Flow | -670.00M | 2.13B | -500.00M | -1.89B | -827.00M | -9.00M |
| Financing Cash Flow | -983.00M | -5.64B | -4.69B | -3.09B | -1.74B | -2.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.88B | 7.75 | ― | 2.37% | 2.65% | 7.45% | |
75 Outperform | ¥168.50B | 12.18 | ― | 2.81% | 12.49% | 26.21% | |
73 Outperform | ¥2.98B | 14.75 | ― | 2.71% | -5.13% | -3.43% | |
73 Outperform | ¥83.57B | 14.69 | ― | 3.46% | -9.03% | -33.40% | |
70 Outperform | ¥8.33B | 5.35 | ― | 2.03% | 26.86% | 0.06% | |
65 Neutral | ¥21.07B | -39.49 | ― | 3.59% | 4.27% | 50.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |